SCHEMBL7535112

SCHEMBL7535112

CCCNc1cc(Cl)ccc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.46
LMNA P02545 1/20 0.46
TDP1 Q9NUW8 3/20 0.45
THRB P10828 1/20 0.45
RECQL P46063 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
RAPGEF4 Q8WZA2 1/20 0.44
GAA P10253 3/20 0.44
MCL1 Q07820 1/20 0.41
IDO1 P14902 1/20 0.41
HTR1A P08908 1/20 0.40
HTT P42858 1/20 0.40
EPHX1 P07099 1/20 0.40
TP53 P04637 1/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
NR1I2 O75469 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7531364 0.84 LMNA (0.58) POLBMEN1KMT2ASMN1; SMN2LMNA
SCHEMBL3398998 0.83 MEN1 (0.50) POLBMEN1KMT2ASMN1; SMN2LMNA
SCHEMBL7530787 0.82 CNR2 (0.45) SMN1; SMN2TDP1RAPGEF4GAAIDO1
SCHEMBL22791495 0.82 GAA (0.58) POLBSMN1; SMN2LMNARECQLRAPGEF4
Hydrochloric Acid SCHEMBL6518247 0.82 MEN1 (0.48) POLBMEN1KMT2ASMN1; SMN2LMNA
SCHEMBL11749251 0.80 LMNA (0.58) POLBMEN1KMT2ALMNAIDO1
SCHEMBL6582851 0.80 KMT2A (0.52) POLBMEN1KMT2ASMN1; SMN2LMNA
SCHEMBL11112106 0.78 CCR1 (0.46) POLBMEN1KMT2ATDP1RAPGEF4
SCHEMBL11246752 0.78 SMN1; SMN2 (0.59) POLBMEN1KMT2ASMN1; SMN2LMNA
SCHEMBL7529401 0.78 TDP1 (0.66) TDP1GAAHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020137740-A1 Aminothiazole derivatives, process for preparing them and pharmaceutical compositions containing them FONTAINE EVELYNE (FR) 2002-09-26 US disclosed
EP-0934290-B1 AMINOTHIAZOLE DERIVATIVES, METHOD OF PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME SANOFI SYNTHELABO (FR) 2002-04-17 EP disclosed
US-6344470-B1 Aminothiazole derivatives, method of preparation and pharmaceutical compositions containing same SANOFI-SYNTHELABO (FR) 2002-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020137740-A1 Aminothiazole derivatives, process for preparing them and pharmaceutical compositions containing them CRHR1, ADRA1D, ADRB1 POLB 4754/4885MEN1 2208/4885KMT2A 2618/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.